Earnings · US stocks
Xeris Biopharma Holdings, Inc. (XERS) earnings
Xeris Biopharma Holdings, Inc. published its quarterly report on 2026-11-05. The stock moved +51.63% in the 3 trading days after the report.
- Report
- quarterly report
- Published
- 2026-11-05
- Result
- Great
Stock move after the report
Trading days from the first tradeable session; dividend-adjusted. "vs index" is the excess return over CSI 300 for A-shares.
| After | Return | vs index |
|---|---|---|
| 1 day | +25.05% | — |
| 3 days | +51.63% | — |
| 7 days | +59.27% | — |
Report history
Over the last 8 reports, EPS beat the consensus estimate in 5 of them. The stock rose in the 3 trading days after 5 of 8 reports (average +13.75%).
| Published | EPS | EPS surprise | 3 days after | 30 days after | 30d vs index |
|---|---|---|---|---|---|
| 2026-11-05 | 0.06 | +124.97% | +51.63% | — | — |
| 2026-05-07 | 0.01 | +1592.54% | -3.61% | +9.11% | +7.35% |
| 2026-03-02 | 0.06 | +33.33% | -0.82% | -2.45% | -2.47% |
| 2025-08-07 | -0.01 | +66.67% | +31.15% | +51.18% | +46.53% |
| 2025-05-08 | -0.06 | -50.00% | +10.49% | +0.67% | -5.23% |
| 2025-03-06 | -0.03 | -50.00% | +21.75% | +8.22% | +18.07% |
| 2024-11-08 | -0.06 | +21.05% | -6.25% | +3.87% | +4.62% |
| 2024-08-08 | -0.10 | -6.38% | +5.63% | +38.97% | +28.88% |
The last 8 reported quarters. Moves count trading days from the first tradeable session after the report; "30d vs index" is the excess return over the market index.
How to read this
Results are grouped by reported profit growth (great, good, neutral, bad or a loss). For China A-shares the quality score starts at 100 and loses points for gaps a reader can check: operating cash falling short of profit, receivables or inventory outrunning revenue, profit that rests on one-off items or subsidies, heavy goodwill and a qualified audit opinion.
Figures are generated automatically from Wave Radar's published market data and refresh after each market close.